68Indexed trials
Market Rank #37 · Evidence Tier A
Chile
Neuroscience Intelligence
Chile neuroscience intelligence: 68 indexed trials, 20 institutions, research score 31.06.
20Recruiting
20Research institutions
31.1Research score
Evidence profile
32Sponsors
16Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 31.1 · Data confidence 100.00 · Evidence 31.1
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons27trials
alzheimers10trials
epilepsy5trials
depression5trials
other_psychiatry3trials
pain_neuropathy3trials
anxiety3trials
schizophrenia2trials
bipolar_disorder2trials
stroke2trials
Leading indexed sponsors
Merck Sharp & Dohme LLC24trials
Pfizer5trials
Pontificia Universidad Catolica de Chile4trials
Hoffmann-La Roche3trials
GlaxoSmithKline3trials
Boehringer Ingelheim2trials
Xenon Pharmaceuticals Inc.2trials
Bristol-Myers Squibb1trials
Axovant Sciences Ltd.1trials
Eisai Inc.1trials